← Browse by Condition
Medical Condition
sclc
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1, Phase 1, Phase 2
NCT05130255 Phase 1
Recruiting
GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2
Enrollment
60 pts
Location
United States
Sponsor
Y-mAbs Therapeutics
NCT04585750 Phase 1, Phase 2
Recruiting
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Enrollment
300 pts
Location
United States, Austr...
Sponsor
PMV Pharmaceuticals, Inc
NCT04686682 Phase 1, Phase 2
Recruiting
A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors
Enrollment
152 pts
Location
China
Sponsor
Jacobio Pharmaceuticals Co., L...